(Q88586616)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Thomas J Semrad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Edward J Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Michael S Tanaka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Jacob Sands

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Chris Roberts

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Rebekah A Burich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Yu Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

David R Gandara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Primo Lara

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Philip C Mack

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

1 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

Cancer Treatment and Research Communications

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

21-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

25 March 2020

cites work

1 reference

12 December 2020

Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity

1 reference

12 December 2020

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance

1 reference

12 December 2020

Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer

1 reference

12 December 2020

Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Pathways mediating resistance to vascular endothelial growth factor-targeted therapy

1 reference

12 December 2020

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.

1 reference

12 December 2020

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

1 reference

12 December 2020

Modes of resistance to anti-angiogenic therapy

1 reference

12 December 2020

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

12 December 2020

Fibroblast growth factor signalling: from development to cancer

1 reference

12 December 2020

Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer

1 reference

12 December 2020

Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma

1 reference

12 December 2020

The multi-tyrosine kinase inhibitor TKI258, alone or in combination with RAD001, is effective for treatment of human leukemia with BCR-ABL translocation in vitro

1 reference

12 December 2020

Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy

1 reference

12 December 2020

In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models

1 reference

12 December 2020

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

12 December 2020

10.1016/J.CTARC.2016.12.002

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28736761%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

PubMed publication ID

28736761

1 reference